Effect of SRT2379 on Endotoxin-Induced Inflammation
Clinical trial NCT01262911 · COMPLETED
Trial details
- NCT number
- NCT01262911
- Sponsor
- Sirtris, a GSK Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-17
- Primary completion
- 2011-04-26
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.